{"schema_version":"1","generated_at":"2026-11-07T15:16:49.350Z","data_as_of":null,"url":"https://www.findmykol.com/kol/anjulika-chawla","json_url":"https://www.findmykol.com/kol/anjulika-chawla/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"anjulika-chawla","name":"Anjulika Chawla","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Lebanon","state":"NH","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1619921129","openalex":"A5109660579"},"summary":"Anjulika Chawla is an Oncology physician. OpenAlex indexes 32 publications with 498 citations (h-index 12); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":32,"cited_by_count":498,"h_index":12,"latest_activity_year":2026,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04628585","title":"Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy","status":"ENROLLING_BY_INVITATION","role":"Overall official","sponsor":"Genetix Biotherapeutics Inc.","source_url":"https://clinicaltrials.gov/study/NCT04628585","trial_url":"https://www.findmykol.com/trial/NCT04628585"},{"nct":"NCT04293185","title":"A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease","phase":"PHASE3","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Genetix Biotherapeutics Inc.","source_url":"https://clinicaltrials.gov/study/NCT04293185","trial_url":"https://www.findmykol.com/trial/NCT04293185"},{"nct":"NCT02140554","title":"A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease","phase":"PHASE1/PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Genetix Biotherapeutics Inc.","source_url":"https://clinicaltrials.gov/study/NCT02140554","trial_url":"https://www.findmykol.com/trial/NCT02140554"}],"source":"trials"},"prescribing":{"data_year":2020,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":1,"classes":[{"class":"Antimetabolite","setting":"prescribed","share_pct":100,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":32,"shown":5,"withheld":27,"matched_by":"OpenAlex author record","recent":[{"title":"Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia","year":2026,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2025029196","status":"verified"},{"title":"Pre-Transplant Immunomodulation Enables Successful Infusion of Genetically Modified Cells in a Sickle Cell Patient","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.12.972","status":"verified"},{"title":"Accelerating Access to Gene Therapy: Lessons from Commercial Implementation in Sickle Cell Disease and Transfusion-Dependent Thalassemia","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.12.959","status":"verified"},{"title":"Durable stroke-free survival after lovotibeglogene-autotemcel in sickle cell disease with prior overt stroke","year":2026,"journal":"Blood Red Cells & Iron","source_url":"https://doi.org/10.1016/j.brci.2026.100137","status":"verified"},{"title":"An Update on Lovotibeglogene Autotemcel (Lovo-cel) Clinical Trials for Sickle Cell Disease (SCD) and Analysis of Early Predictors of Response to Lovo-Cel","year":2025,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.01.390","status":"verified"}],"source":"works"},"contact":{"address_1":"1 MEDICAL CENTER DR","city":"Lebanon","state":"NH","zip":"037561000","phone":"603-650-5000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1619921129","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":27}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-03-03","provider_certified":"2023-03-03","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2020}},"methodology_url":"https://www.findmykol.com/about#methodology"}